Cost Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as Comorbidity

Chowdhury Enayet K.; Ademi Zanfina; Moss John R.; Wing Lindon M. H.; Reid Christopher M.

首页> 外文期刊>Medicine. >Cost Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as Comorbidity

【24h】

Cost Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as Comorbidity

机译：在以糖尿病为合并症的澳大利亚老年人中，以血管紧张素转换酶抑制剂为基础的治疗与以噻嗪类利尿剂为基础的治疗相比，其成本效用高

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The objective of this study was to examine the cost-effectiveness of angiotensin-converting enzyme inhibitor (ACED-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as an outcome along with cardiovascular outcomes from the Australian government's perspective.

机译：这项研究的目的是从澳大利亚政府的角度探讨将血管紧张素转换酶抑制剂（基于ACED的治疗与基于噻嗪类利尿剂的治疗）对老年澳大利亚人的高血压的成本效果，并将糖尿病与心血管疾病作为结果。

著录项

来源
《Medicine. 》 |2015年第9期| 共9页
作者
Chowdhury Enayet K.; Ademi Zanfina; Moss John R.; Wing Lindon M. H.; Reid Christopher M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生 ;
关键词

相似文献

外文文献
中文文献
专利

1. Cost–Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as Comorbidity [J] . Chowdhury Enayet K., Ademi Zanfina, Moss John R., Medicine. . 2015 ,第9期

机译：在以糖尿病为合并症的澳大利亚老年人中，以血管紧张素转换酶抑制剂为基础的治疗与以噻嗪类利尿剂为基础的治疗相比，成本效用高
2. Cost Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as Comorbidity [J] . Chowdhury Enayet K., Ademi Zanfina, Moss John R., Medicine. . 2015 ,第9期

机译：基于血管紧张素转化酶抑制剂的成本效用与考虑糖尿病作为合并症的老年澳大利亚人高血压治疗相比
3. COST-EFFECTIVENESS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-BASED COMPARED TO THIAZIDE DIURETIC-BASED TREATMENT IN AN ELDERLY HYPERTENSIVE POPULATION CONSIDERING DIABETES AS A MAJOR COMORBIDITY [J] . Chowdhury E., Ademi Z., Moss J., Hypertension: An Official Journal of the American Heart Association . 2015 ,第5期

机译：在以糖尿病为主要合并症的高龄高血压人群中，基于血管紧张素转换酶抑制剂的治疗与基于噻嗪类利尿剂的治疗相比
4. Rule-Based Combination of Comorbid Treatments for Chronic Diseases Applied to Hypertension, Diabetes Mellitus and Heart Failure [C] . Joan Albert Lopez-Vallverdu, David Riano, Antoni Collado International conference on business process management . 2013

机译：基于规则的高血压，糖尿病和心力衰竭慢性病合并治疗组合
5. The use of the transition cost accounting system to compare costs of treatment between Canada and the United States: Methodological issues based on the case of acute myocardial infarction. [D] . Azoulay, Arik. 2001

机译：使用过渡成本核算系统比较加拿大和美国之间的治疗成本：基于急性心肌梗塞病例的方法学问题。
6. Cost–Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as Comorbidity [O] . Enayet K. Chowdhury, Zanfina Ademi, John R. Moss, -1

机译：在以糖尿病为合并症的澳大利亚老年人中以血管紧张素转换酶抑制剂为基础的治疗与以噻嗪类利尿剂为基础的治疗相比成本效用高
7. Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity [O] . Chowdhury E., Ademi Z., Moss J., 2015

机译：基于血管紧张素转换酶抑制剂治疗的成本 - 效用与噻嗪类利尿剂治疗高血压的老年澳大利亚人认为糖尿病合并症

Cost Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as Comorbidity

摘要

著录项

相似文献

相关主题

期刊订阅